Myosin 2 maintains an open exocytic fusion pore in secretory epithelial cells.
Many studies have implicated F-actin and myosin 2 in the control of regulated secretion. Most recently, evidence suggests a role for the microfilament network in regulating the postfusion events of vesicle dynamics. This is of potential importance as postfusion behavior can influence the loss of vesicle content and may provide a new target for drug therapy. We have investigated the role of myosin 2 in regulating exocytosis in secretory epithelial cells by using novel assays to determine the behavior of the fusion pore in individual granules. We immunolocalize myosin 2A to the apical region of pancreatic acinar cells, suggesting it is this isoform that plays a role in granule exocytosis. We further show myosin 2 phosphorylation increased on cell stimulation, consistent with a regulatory role in secretion. Importantly, in a single-cell, single-granule secretion assay, neither the myosin 2 inhibitor (-)-blebbistatin nor the myosin light chain kinase inhibitor ML-9 had any effect on the numbers of granules stimulated to fuse after cell stimulation. These data indicate that myosin 2, if it has any action on secretion, must be targeting postfusion granule behavior. This interpretation is supported by direct study of fusion pore opening in which we show that (-)-blebbistatin and ML-9 promote fusion pore closure and decrease fusion pore lifetimes. Our work now adds to a growing body of evidence showing that myosin 2 is an essential regulator of postfusion granule behavior. In particular, in the case of the secretory epithelial cells, myosin 2 activity is necessary to maintain fusion pore opening.
Bhat
Purnima
P
School of Biomedical Sciences, University of Queensland, Brisbane, Queensland, QLD 4072, Australia.
Thorn
Peter
P
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D004847:Epithelial Cells / Q000187:drug effects / Q000378:metabolism*; D005089:Exocytosis; D007425:Intracellular Membranes / Q000187:drug effects / Q000378:metabolism; D008561:Membrane Fusion / Q000187:drug effects; D051379:Mice; D024462:Myosin Type II / Q000378:metabolism*; D010766:Phosphorylation; D016062:Porosity; D013997:Time Factors
D024462:Myosin Type II; D000109:Acetylcholine